#TumorBoardTuesday // #BladderCancer Treatment upon Progression #UrothelialCancer

#TumorBoardTuesday #BladderCancer @MattGalsky @JonAnker1 📅Tues, 11/2922 8PM ET ✅polls ⚖️in & bring citations🧾 🔁Retweet & tag your colleagues 🏆Earn your🆓CME (AMA & MOC) https://t.co/63osUKM6ij Before the case:🧐tell us where you are in your 🩺journey👇👇👇

#TumorBoardTuesday #BladderCancer @MattGalsky @JonAnker1 📅Tues, 11/2922 8PM ET ✅polls ⚖️in & bring citations🧾 🔁Retweet & tag your colleagues 🏆Earn your🆓CME (AMA & MOC) https://t.co/63osUKM6ij Before the case:🧐tell us where you are in your 🩺journey👇👇👇

#TumorBoardTuesday #PreTest❓Free #CME🔗: https://t.co/63osUKM6ij 🤔B4⃣ @MattGalsky & @JonAnker1 🗣️immunotherapy for progressive #BladderCancer, test your 🧠 with these 2 Q's What would you select for1⃣st line Tx for a patient with Stage 4 Bladder Cancer, and a GFR = 15❓

🦃The above & upcoming #TumorBoardTuesday discussion with moderators @MattGalsky @JonAnker1 is provided by @IntegrityCE 🦃Supported by educational grants from @AstraZeneca, Exelixis, & Merck Sharp & Dohme Corp 🦃More info about our free CME & MOC: https://t.co/63osUKtX4b

@TumorBoardTues @MattGalsky @IntegrityCE @AstraZeneca 67 yo 👨‍🦱with gross hematuria🩸x3 month h/o CAD CKD3b DM2 🩻CT: 👇🏽see attached👇🏽 Cystoscopy and TURBT: high grade MIBC 🔬Liver bx: metastatic UC 🧪PD-L1 CPS 5% 🧬no FGFR mutation @MattGalsky


@JonAnker1 @TumorBoardTues @MattGalsky @IntegrityCE @AstraZeneca @tarekmd91 @michelle_a_tran @kai_tsao @GeneticsRach @sonpavde @roula_almufti @JLVasquez82 @MichalisLiontos @alirezaghoreifi @montypal Actually just today a patient of ours came asking how serious “stage 3” kidney disease was as she saw that diagnosis listed for her on MyChart and it sounded ominous knowing cancer stages. So here is a reminder that there is a stage 5 … in nephrology https://t.co/ZXJLZIxFfU


@TumorBoardTues @MattGalsky @IntegrityCE @AstraZeneca @tarekmd91 @michelle_a_tran @kai_tsao @GeneticsRach @sonpavde @roula_almufti @JLVasquez82 @MichalisLiontos @alirezaghoreifi @montypal 👨‍🦱 Patient heard about immune therapies, asks how that compares to chemotherapy. 👨‍🦱🤝👨🏻‍⚕️Discussed starting treatment 💉 #SharedDecision 🤨 What would you offer this patient?

1/7 #TumorBoardTuesday 🔬🧬Immunotherapy improves outcomes in stage II/III #TNBC–but can IO be safely given in autoimmune disease? A led by

➡️ Thursday Case 🎀 🆓#CME: answer 2 quick ALL CME 🔗: integrityce.com/TBT2023